Table 3.
Quality Assessment of Included Case Series
| Martin et al,32 2006 | Henderson et al,25 1991 | Geile et al,24 2019 | Algren et al,20 2013 | Lee et al,30 2016 | Denton et al,22 2008 | Jones et al,26 2008 | Mercado et al,33 2014 | Krinsky et al,28 2011 | |
|---|---|---|---|---|---|---|---|---|---|
| Were there clear criteria for inclusion in the case series? | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✖ | ✔ | – |
| Was the condition measured in a standard, reliable way for all participants included in the case series? | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| Were valid methods used for identification of the condition for all participants included in the case series? | ✔ | ✔ | ✔ | ✖ | ✔ | ✔ | ✖ | ✔ | ✔ |
| Did the case series have consecutive inclusion of participants? | ✔ | ✖ | ✔ | ✔ | ✔ | ✔ | ✖ | ✔ | – |
| Did the case series have complete inclusion of participants? | ✔ | ✖ | ✔ | – | ✔ | ✔ | ✖ | ✔ | ✖ |
| Was there clear reporting of the demographics of the participants in the study? | ✖ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| Was there clear reporting of clinical information of the participants? | ✔ | ✔ | ✔ | ✔ | ✔ | – | ✖ | ✔ | ✖ |
| Were the outcomes or follow up results of cases clearly reported? | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Was there clear reporting of the presenting site(s)/clinic(s) demographic information? | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| Was statistical analysis appropriate? | – | – | – | ✔ | – | – | – | ✔ | – |